Emerging therapies of hemangioblastomas

Article Properties
  • Language
    English
  • Publication Date
    2023/12/29
  • Refrences
    83
  • Chaitanya Sanghadia Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85721, USA ORCID (unauthenticated)
  • Melanie E. Martinez Department of Neuroscience, University of Florida, Gainesville, Florida 32611, USA ORCID (unauthenticated)
  • Marisa McNulty Department of Neurosurgery, University of Florida, Gainesville, Florida 32611, USA ORCID (unauthenticated)
  • Eric Russ Department of Neurosurgery, University of Florida, Gainesville, Florida 32611, USA ORCID (unauthenticated)
  • Maxwell Woolridge Department of Neurosurgery, University of Florida, Gainesville, Florida 32611, USA
  • Dat Thanh Cao Department of Neurosurgery, University of Florida, Gainesville, Florida 32611, USA ORCID (unauthenticated)
  • Marko Micunovic Department of Neurosurgery, University of Florida, Gainesville, Florida 32611, USA ORCID (unauthenticated)
  • Jeffery Roberts Department of Otolaryngology, University of Florida, Gainesville, Florida 32611, USA
  • Juan Perez Department of Neurosurgery, University of Florida, Gainesville, Florida 32611, USA
  • Brandon Lucke-Wold Department of Neurosurgery, University of Florida, Gainesville, Florida 32611, USA ORCID (unauthenticated)
Abstract
Cite
Sanghadia, Chaitanya, et al. Emerging Therapies of Hemangioblastomas. no. 6, 2023, pp. 318-30, https://doi.org/10.37349/en.2023.00031.
Sanghadia, C., Martinez, M. E., McNulty, M., Russ, E., Woolridge, M., Cao, D. T., Micunovic, M., Roberts, J., Perez, J., & Lucke-Wold, B. (2023). Emerging therapies of hemangioblastomas. 2(6), 318-330. https://doi.org/10.37349/en.2023.00031
Sanghadia, Chaitanya, Melanie E. Martinez, Marisa McNulty, Eric Russ, Maxwell Woolridge, Dat Thanh Cao, Marko Micunovic, Jeffery Roberts, Juan Perez, and Brandon Lucke-Wold. “Emerging Therapies of Hemangioblastomas” 2, no. 6 (2023): 318-30. https://doi.org/10.37349/en.2023.00031.
1.
Sanghadia C, Martinez ME, McNulty M, Russ E, Woolridge M, Cao DT, et al. Emerging therapies of hemangioblastomas. 2023;2(6):318-30.
Refrences
Title Journal Journal Categories Citations Publication Date
The incidence of consecutive manifestations in Von Hippel-Lindau disease Familial Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Science: Biology (General): Genetics
  • Medicine: Medicine (General)
14 2019
Safety and efficacy of surgical treatment for brainstem hemangioblastoma: a meta-analysis

Neurosurgical Review
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
  • Medicine: Surgery
  • Medicine: Medicine (General)
8 2020
Incidence, Prognostic Factors and Survival for Hemangioblastoma of the Central Nervous System: Analysis Based on the Surveillance, Epidemiology, and End Results Database Frontiers in Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
18 2020
Radiation-induced cognitive toxicity: pathophysiology and interventions to reduce toxicity in adults Neuro-Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
59 2017
MANAGEMENT OF RETINAL HEMANGIOBLASTOMA IN VON HIPPEL–LINDAU DISEASE

Retina
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
2 2019